Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top London based CEO’ operating in the Medical Device space. If you think a CEO’ is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Jean-luc Bressard
CEO of Hextransforma Healthcare
Social equality campaigner and entrepreneur
Follow Jean-luc Bressard:
About Dolerite Ltd, Hextransforma Healthcare, Time to Shine Kids: Telemedicine and digital healthcare solution provider. Owner of the Brit-Med.com medical tourism platform
Nader Alaghband
Co-Founder & CEO of Ampersand Health
Follow Nader Alaghband:
About Ampersand Health: Ampersand creates innovative digital medicines for complex long term conditions, using behavioural and data-science.
Sokratis Papafloratos
CEO of Numan
Sokratis Papafloratos works as a Founder and CEO at Togethera. Previously CEO & co-founder of TrustedPlaces, acquired by Yell Group in 2010. Engineering degree from York University.
Follow Sokratis Papafloratos:
About Numan, TrustedPlaces: Numan: Helping Your Health Wherever We Can
John E. Milad
CEO & Founder of Quanta
John E. Milad is a global healthcare executive, board member, investor, speaker and author. He has a career spanning over 25 years, with experience working in various senior positions in the healthcare sector, including NBGI Ventures, Atlas Venture, Nitec Pharma and Nomura. Currently, John is Chief Executive Officer and founding board member at Quanta Dialysis Technologies, where he recently raised $245m in Series D funding. An executive with international experience in building and growing successful healthcare companies, John had the vision and belief that core technology of managing fluidics on a disposable cartridge could be developed into a portable hemodialysis device with the potential to address multiple unmet needs in the $93 billion global dialysis market. John is a regular speaker and panelist at global medtech and investment conferences and has co-authored 4 peer-reviewed papers.
Follow John E. Milad:
About NBGI Ventures, Quanta: Quanta develops an advanced haemodialysis systems for use in the home and clinic.
Ali Rezaei Haddad
CEO and Founder of NeuroNav
Ali is a neurosurgical resident in London and an NHS Clinical Entrepreneur. Prior to this, he completed his Academic Foundation Training in the Medical Sciences Division at the University of Oxford undertaking research in the field of neuroimaging. He graduated with first class honours in Neurosciences BSc at Imperial College London, and he holds honorary research positions at the University of Oxford and St George’s Medical School. Ali co-founded the internationally acclaimed GoodSAM app used by the NHS, in which clinically trained individuals sign up as volunteers to respond to life-threatening emergency calls. He also directed and curated the Imagining the Future of Medicine at the Royal Albert Hall in partnership with TEDMED, attended by a live audience of 5,000 people. Inspired by the lack of user friendly and affordable neuronavigation solutions worldwide, he founded NeuroNav to democratise access to neurosurgery navigation solutions.
Follow Ali Rezaei Haddad:
About Imperial College Healthcare NHS Trust, NeuroNav: An augmented reality neuronavigation platform powered by computer vision and machine learning.
Sina Habibi
CEO of Cognetivity Neurosciences
Sina Habibi is the CEO at Cognetivity Neurosciences.
Follow Sina Habibi:
About Cognetivity Neurosciences: Cognetivity Neurosciences is a Platform technology for early, rapid and easy detection of dementia.
Carina Cunha
Co-Founder & CEO of Be Nosy
Carina is a business strategist and inventor of Nosy with passion for science, sales and marketing. In her former role as MD and Launcher of Crimson Education Europe, she created sales, marketing and service delivery teams from scratch, achieving millions in ARR and 150%+ YoY growth. Prior to working with startups Carina was corporate strategist at JPMorgan, Strategy Consultant at Accenture, Investment Banker at Credit Suisse, and a fashion model with Elite. Carina is also an innovation and commercial consultant through Meta Strategy and Founders Intelligence where she helps startups and scale-ups find product-market fit and corporates build new revenue lines. She has a B.A. from Columbia University and PgD. from the University of Edinburgh.
Follow Carina Cunha:
About Be Nosy: Nosy is a MedTech startup developing wearable air filter and air pollution tracking network.
Richard Vincent
CEO & Co-Founder of FundamentalVR
Richard has 20+ years’ experience of building international businesses and has throughout his career sought opportunities for positive market disruption through technological application. It was this desire that led him to co-found FundamentalVR to help address an age-old problem for the medical market; how to create safe, realistic, measurable spaces to learn and develop skills. In his role as CEO Richard is responsible for building a world class team of medical, learning and technologist who together can realise the company’s ambition of creating the world’s first global, haptically enabled, low cost ‘flight simulator for surgeons’.
Follow Richard Vincent:
About Fundamental Surgery, FundamentalVR: FundamentalVR delivers VR haptic ‘flight simulators’ for surgery creating a safe, measurable & repeatable space to refine to refine skills.
Ali Moiyed
CEO & Founder of Aerobit Health
Follow Ali Moiyed:
About Aerobit Health: Breathing New Life Into Asthma Care
Krishan Ramdoo
CEO and Founder of Tympa Health Technologies LTD
Krishan Ramdoo is the CEO and Founder of TympaHealth Technologies.
Follow Krishan Ramdoo:
About Tympa Health Technologies LTD: TympaHealth are a team of doctors and technology experts united in their vision of helping the world to hear.
Thang Vo-Ta
CEO & Co-Founder of Callaly
Co-founder & CEO at Callaly.Thang is a graduate of MIT and started his career in Goldman Sachs in NYC & London.
Follow Thang Vo-Ta:
About Callaly: Callaly is a period care company that develops and manufactures innovative feminine care products.
Emilio Sanz Pereiras
CEO of Acurable
Emilio is a serial entrepreneur and leads Acurable’s strategy, operations and commercialisation activities. Emilio spent the last 15 years building 3 successful start-ups across Europe and Asia, where he learned first hand how to successfully commercialise highly innovative technologies and how to to scale start-up operations in both B2B and B2C industries. Originally from Spain, Emilio holds a MSc in Electrical Engineering from Telecom ParisTech, a MSc in Computer Science from the Polytechnic University of Madrid and an MBA from London Business School.
Follow Emilio Sanz Pereiras:
About Acurable: The first wearable medical device able to accurately diagnose and manage respiratory conditions at home
Katerina Spranger
Founder and CEO of Oxford Heartbeat
Katerina is the Fellow of the Royal Academy of Engineering. She holds a PhD in Biomedical Engineering from the University of Oxford and was previously a researcher in AI at the Sony Computer Science Laboratory in Paris.
Follow Katerina Spranger:
About Oxford Heartbeat, Royal Academy of Engineering: Oxford Heartbeat makes cardiovascular surgery more accurate and safe.
Ema Kufel
Co-Founder, CEO of Prosoma
Co-Founder/CEO, Ema is an (MSc) Marketing Communications graduate and an expert in healthcare communications. Ema has vast experience in managing projects developing digital strategies within the National Health Service and the Department of Health in the UK. She is passionate about healthcare and innovation, key components of Prosoma.
Follow Ema Kufel:
About Prosoma: At Prosoma, we design world-leading digital therapeutics solutions for Oncology.
Alexandra Hussenot
Founder & CEO of Immersionn
Alexandra is the founder of Immersionn, the world’s first VR Discovery Engine and she is also the UK lead for ‘Women in Immersive Technologies’, a community of 1000 members that aims to empower European women working in XR. She is also 1 in 10 members of the UK5G Creative Industries working group reporting the department in charge of Digital, Medias, Culture and Sport (DCMS). Prior to this, Alexandra pursued an international business career at insurance firm, Allianz, managing an £80M global business. She has also worked all over Europe during her 11 years at Sony Ericsson (now Sony Mobile) and has solid experience designing and launching software and service products, particularly covering user experience design and continuous improvements. She also lead large scale operations for mobile phone repairs and remanufacturing.
Follow Alexandra Hussenot:
About Immersionn: Immersionn is a content discovery company. We allow people to discover VR content they would never find
Simos Kedikoglou
Chief Executive Officer of Impulse Dynamics
Simos Kedikoglou is the CEO of Impulse Dynamics since 2013 and serves on the Company’s Board of Directors.He was previously CEO of MedInvest, an Israeli Medical Technology Incubator overseeing 10 portfolio companies with responsibility for their clinical and commercial strategy, technology development and debt and equity financing. He has also served as Corporate Vice President of Business Development for Boston Scientific responsible for acquisitions, licensing and distribution deals in the US, Europe and Asia and an Associate Partner with McKinsey & Company in the US advising clients on acquisitions in pharmaceuticals and medical devices. Simos holds a Medical Degree from the University of Athens, Greece, an MBA with distinction from Harvard Business School as well as a Master’s in Public Health from Harvard University, and he is a CFA Charterholder.
Follow Simos Kedikoglou:
About Impulse Dynamics: Impulse Dynamics is a medical device company dedicated to offering innovative solutions for treatment of Chronic Heart Failure (CHF).
George Frodsham
Founder & CEO of MediSieve
George Frodsham founded MediSieve after being awarded his PhD in biochemical engineering from University College London (UCL), during which he developed the magnetic blood filter. As well as being a physicist and engineer, George is an entrepreneur. George was awarded a BBSRC Enterprise Fellowship from the Royal Society of Edinburgh in 2014. Since 1996, only 180 individuals have benefited from this highly competitive and prestigious programme. George has also completed the Entrepreneurship Summer School programme at the London Business School. This equipped him to research target markets and industries and turn his visions into viable businesses.
Follow George Frodsham:
About MediSieve: MediSieve is a therapeutics company developing a platform technology for the treatment of blood-borne diseases.
Ozgur Tuncer
CEO & Executive Director of Stablepharma Ltd
Ozgur Tuncer CEO & Executive Director – two decades of experience in the biopharmaceutical industry including working for blue chip companies such as Pfizer, IQVIA and Pharmacia. Most recently, he was Global Vice President in IQVIA, and strategic adviser to life sciences investors. In addition to his role in Stablepharma, Özgür is an Investment Partner with Ascension Ventures.
Follow Ozgur Tuncer:
About Stablepharma Ltd: An innovative Biotech, developing a wide range of reformulated thermostable and fridge free StablevaX vaccines
Kitty Liao
Founder & CEO of Ideabatic
Royal Academy of Engineering 2018 Enterprise Fellow, Ambassador at THE Port Association, Switzerland. Ten years experience in multi-disciplinary system design and R&D, including low temperature systems, superconducting cavity diagnostics systems and design for low-resource settings.
Follow Kitty Liao:
About Ideabatic: Ideabatic is solving the most challenging humanitarian problems by delivering innovative solutions and devices.
Christophe Berthoux
Chief Executive Officer of NAMSA
Follow Christophe Berthoux:
About NAMSA: NAMSA is a medical research organization speeding product development for medical devices, IVDs, regenerative medicine.
Faii Ong
Founder and CEO of GyroGear
Faii Ong is the founder and CEO of GyroGear.
Follow Faii Ong:
About GyroGear: GyroGear is developing a wearable to help individuals with hand tremors.
Damien McDonald
CEO of LivaNova
Damien McDonald is the Chief Executive Officer of LivaNova. Previously, Mr. McDonald served as Chief Operating Officer of LivaNova. Prior to that, he was Group Executive and Corporate Vice President at Danaher Corporation where he led a $1.5-billion group of dental consumables companies. Earlier in his tenure, he was Group President of Kerr where he and his team focused on building a strong research and development pipeline while improving operational performance utilizing the Danaher Business System. Additionally, Mr. McDonald previously led Zimmer’s spine division where he demonstrated his leadership skills, attracting a strong executive team that created a growth trajectory for the business unit. Earlier in his career, he worked with J&J’s Medical Device Franchises, including Ethicon, where he led marketing of the $2.5-billion medical device unit. Mr. McDonald earned an MBA at the Institute for Management Development (IMD) in Lausanne, Switzerland, along with a Master of Science in International Economics from the University of Wales, U.K. He also holds a Bachelor of Economics degree and Bachelor of Pharmacy degree, both from the University of Queensland, Australia. Mr. McDonald is a non-executive director of the regenerative medicine company Avita Medical (ASX:AVH).
Follow Damien McDonald:
About LivaNova: LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment.
Neel Patel
Founder & Chief Executive Officer of ZiO Health
Follow Neel Patel:
About ZiO Health: ZiO Health has developed proprietary pocket-sized technology, bringing lab testing to the point of use.
Herbert Oakes
Founder & CEO of NOXSUDOR THERAPEUTICS LIMITED
Herbert Oakes, non-executive director, is an investment banker and builder of high technology life sciences companies. He is currently a Managing Director of Oakes, Lyman & Co. Limited an investment banking firm specialising in high-tech healthcare; a Managing director of Hycroft Advisors, a global investment banking firm specialising in arranging capital for private equity partnerships; and CEO of NoxSudor Therapeutics Limited, a start-up medical business developing a therapy for hot flashes and night sweats for menopausal women. He is an advisor of Wilton Corporate Finance Limited.
Follow Herbert Oakes:
About NOXSUDOR THERAPEUTICS LIMITED: First prescription medical device to control sweating
Toby Basey-Fisher
Co-Founder & CEO of Entia
Toby Basey-Fisher serves as a Co-Founder & CEO at Entia.
Follow Toby Basey-Fisher:
About Entia, Imperial College London: Entia is a medical technology company that specializes in improving access to blood test.
Anna Starynska
CEO of Cardiolyse
Follow Anna Starynska:
About Cardiolyse: Cardiolyse is a cloud ECG & HRV analytics platform that provides personalized reports, heart failures detection, and data-based prognosis.
Michal Wlodarski
Chief Executive Officer of Solvemed Group
Cambridge PhD with 8+ years of diverse experience in life sciences spanning emerging technology consulting, venture management, business development, knowledge and technology transfer, academic and industrial R&D, and teaching and mentoring at the graduate level. 5+ years of experience in healthcare & life sciences consulting with a strong skill set spanning business development and sales, client and project management, and expert team leadership across R&D strategy, technology forecasting and scouting, product innovation and technology commercialisation projects. Demonstrated consistently the ability to initiate and develop successful professional relationships, generate new revenue streams, manage diverse stakeholders and expert teams, and lead the delivery of complex high-stake life science innovation projects in high-pace international environments.
Follow Michal Wlodarski:
About Solvemed Group: Revolutionising neurology diagnostics and drug discovery with the power of Artificial Intelligence.
Chris Ball
Chief Executive Officer of Jupiter Diagnostics
Prior to founding Jupiter Diagnostics, Chris launched point-of-care diagnostic tests for Johnson & Johnson in Europe. He has worked as a CEO of a Boston biotech company, as a venture capital investor and a doctor. He has raised more than £40 million for companies he has supported or led.
Follow Chris Ball:
About IQVIA, Jupiter Diagnostics: Jupiter Diagnostics has developed a diagnostic platform
Ashmita Das
Co-founder and CEO of Kolabtree
Follow Ashmita Das:
About Kolabtree: Find & hire experts, top postdocs & PhDs, as research collaborators for your academic or business projects.Speed up your research work!
Hugh Lloyd-Jukes
CEO and Chairman of Oxehealth
Hugh Lloyd-Jukes is the CEO and Chairman at Oxehealth.
Follow Hugh Lloyd-Jukes:
About Oxehealth: SaaS workflow solution gives carers and custodians more time for hands on care where and when it’s needed most.
Charles Large
Founder and CEO of Autifony Therapeutics
Charles Large received his first degree and PhD from the University of Bristol and has more than 20 years of experience of drug discovery and development in the pharmaceutical industry. Before founding Autifony, he was Director of Molecular and Cellular Biology within the Neuroscience Centre of Excellence for Drug Discovery at GlaxoSmithKline, and has worked on programs focused on schizophrenia, Alzheimer’s disease, epilepsy, bipolar disorder, and major depression. He is an expert on drugs that modulate voltage gated ion channels and their application to neurological and psychiatric disorders. He has built up a reputation in the field of sodium channel blocking drugs, and has collaborated widely with academic groups. He has authored over 50 papers, book chapters and patents relating to ion channel modulators.
Follow Charles Large:
About Autifony Therapeutics: Autifony Therapeutics is a biotechnology company developing medicines to treat hearing disorders such as hearing loss and tinnitus.
Richard Hancock
Chief Executive Officer of Blue Maestro
Richard Hancock joined Blue Maestro as Chief Executive Officer in 2012.
Follow Richard Hancock:
About Blue Maestro: Environment and health monitoring solutions from developing innovative Bluetooth devices to hosting a cloud platform for sensor telemetrics.
Hugo Macedo
CEO & Founder of Smart Separations Ltd
Hugo is the founder and CEO of Smart Separations Ltd. He has over 11 years of experience in entrepreneurship which helped him founding this start-up company that has developed a proprietary filter that can be tailored to suit many different applications in the poorly explored but very large microfiltration market, from biotechnology to food & drink processing. Throughout his PhD in Biomedical Engineering, Hugo was constantly challenged with new and diverse tasks, in a multidisciplinary environment, where he breathed skills from chemical engineering to stem cell technology, including membrane technology, hydrodynamics, stem cell culture and bioprocessing, human blood production, amongst many others. This provided him with the right tools to create the first “3D hollow fibre bioreactor for the production of human red blood cells” – a system design that he patented. This work was featured in different magazines, including the cover page of The Chemical Engineer (TCE) in 2011, selected as one of “Ten life-changing ideas under research at UK universities” by the Research Councils UK and shortlisted for the highly prestigious IChemE Awards in 2011. Hugo currently holds 2 patents and is passionate for innovation leading to improve people’s quality of life – a vision that he has shared with Smart Separation
Follow Hugo Macedo:
About Smart Separations Ltd: Smart Separations is a limited company based in London UK that has patented an innovative microfiltration technology.
Sukhbinder Noorpuri
Founder & CEO of i-GP
With over 15 years of NHS experience, Dr Noorpuri founded i-GP to improve patient access to care that is convenient, affordable and safe.
Follow Sukhbinder Noorpuri:
About i-GP: i-GP is an online service that provides customers with medical services and advice.
